Brian A. Leuthner

2018 - Edge Therapeutics

In 2018, Brian A. Leuthner earned a total compensation of $4.4M as Chief Executive Officer at Edge Therapeutics, a 72% increase compared to previous year.

Compensation breakdown

Bonus$318,000
Option Awards$3,356,300
Salary$530,000
Stock Awards$143,846
Other$7,488
Total$4,355,634

Leuthner received $3.4M in option awards, accounting for 77% of the total pay in 2018.

Leuthner also received $318K in bonus, $530K in salary, $143.8K in stock awards and $7.5K in other compensation.

Rankings

In 2018, Brian A. Leuthner's compensation ranked 2,480th out of 14,244 executives tracked by ExecPay. In other words, Leuthner earned more than 82.6% of executives.

ClassificationRankingPercentile
All
2,480
out of 14,244
83rd
Division
Manufacturing
915
out of 5,765
84th
Major group
Chemicals And Allied Products
312
out of 2,128
85th
Industry group
Drugs
254
out of 1,817
86th
Industry
Pharmaceutical Preparations
197
out of 1,391
86th
Source: SEC filing on August 15, 2019.

Leuthner's colleagues

We found four more compensation records of executives who worked with Brian A. Leuthner at Edge Therapeutics in 2018.

2018

W Middlekauff

Edge Therapeutics

General Counsel

2018

Herbert Faleck

Edge Therapeutics

Chief Medical Officer

2018

Andrew Saik

Edge Therapeutics

Chief Financial Officer

2018

R Macdonald

Edge Therapeutics

Chief Scientific Officer

News

In-depth

You may also like